📰 Amaru Kishan News
Amaru Kishan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amaru Kishan. Real-time updates on events, politics, business and more.
April 19, 2024
No difference in freedom from distant metastasis or overall survival at 10 years
January 9, 2024
Although MRI detects radiorecurrent cancer overall, it may not accurately locate all lesions in the prostate gland. Investigators studied the role of MRI for detecting radiorecurrent prostate cancer for salvage focal therapy.
December 8, 2023
Study findings suggest that barriers exist in equitable administration of novel hormone therapy. Underuse of novel hormonal therapy agents in Black men with advanced prostate cancer continues and may be detrimental to their health.
October 16, 2023
The phase 3 PACE-B trial demonstrated that stereotactic body radiation therapy is noninferior to conventional radiation therapy for low- and favorable-intermediate-risk prostate cancer with respect to biochemical clinical failure. Stereotactic body radiation therapy is noninferior to conventional external beam radiation therapy for low- and favorable-intermediate-risk prostate cancer.
October 13, 2023
Identifying surrogate endpoints for use in clinical trials that strongly predict clinical outcomes such as improved survival and quality of life is challenging.
September 22, 2023
Identifying surrogate endpoints for use in clinical trials that strongly predict clinical outcomes such as improved survival and quality of life is challenging.
September 5, 2023
As an early event, biochemical recurrence (BCR) in prostate cancer garnered great interest as a potential surrogate trial endpoint for overall survival.
April 18, 2023
SOUTH SAN FRANCISCO - Veracyte, Inc. announced that new data published in European Urology Oncology suggest the Decipher Prostate Genomic Classifier could help identify prostate cancer patients who... | April 18, 2023
April 17, 2023
Findings published in European Urology Oncology suggest genomic classifier scores are highly correlated with PSMA PET upstaging of prostate cancer in those with high-risk and very high-risk disease ... | April 17, 2023
April 3, 2023
Dr Kishan discusses the use of MRI-guided SBRT in prostate cancer to reduce acute genitourinary and gastrointestinal toxicity; findings from the MIRAGE study; and how MRI-guided SBRT allows for tighter planning margins, thereby reducing both physician-reported and patient-reported bowel and bladder toxicities.